A detailed history of Goldman Sachs Group Inc transactions in Geron Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 17,940,973 shares of GERN stock, worth $71.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,940,973
Previous 11,297,679 58.8%
Holding current value
$71.6 Million
Previous $47.9 Million 70.04%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $27.7 Million - $33.2 Million
6,643,294 Added 58.8%
17,940,973 $81.5 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $21.4 Million - $35.2 Million
6,906,997 Added 157.31%
11,297,679 $47.9 Million
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $2.12 Million - $4.16 Million
1,210,279 Added 38.05%
4,390,682 $14.5 Million
Q4 2023

Feb 13, 2024

SELL
$1.74 - $2.31 $589,962 - $783,226
-339,059 Reduced 9.63%
3,180,403 $6.71 Million
Q3 2023

May 14, 2024

BUY
$2.11 - $3.28 $715,414 - $1.11 Million
339,059 Added 10.66%
3,519,462 $7.46 Million
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $216,450 - $336,472
102,583 Added 3.0%
3,519,462 $7.46 Million
Q2 2023

May 14, 2024

BUY
$1.97 - $3.69 $2.01 Million - $3.76 Million
1,019,826 Added 42.54%
3,416,879 $11 Million
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $2.01 Million - $3.76 Million
1,019,826 Added 42.54%
3,416,879 $11 Million
Q1 2023

May 14, 2024

BUY
$2.14 - $3.4 $2.68 Million - $4.26 Million
1,251,703 Added 109.29%
2,397,053 $5.2 Million
Q1 2023

May 11, 2023

BUY
$2.14 - $3.4 $2.68 Million - $4.26 Million
1,251,703 Added 109.29%
2,397,053 $5.2 Million
Q4 2022

May 14, 2024

BUY
$2.03 - $2.42 $441,797 - $526,674
217,634 Added 23.46%
1,145,350 $2.77 Million
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $441,797 - $526,674
217,634 Added 23.46%
1,145,350 $2.77 Million
Q3 2022

May 14, 2024

BUY
$1.67 - $2.94 $296,931 - $522,740
177,803 Added 23.71%
927,716 $2.17 Million
Q3 2022

Nov 10, 2022

BUY
$1.67 - $2.94 $296,931 - $522,740
177,803 Added 23.71%
927,716 $2.17 Million
Q2 2022

May 14, 2024

SELL
$1.19 - $1.65 $2.89 Million - $4.01 Million
-2,430,490 Reduced 76.42%
749,913 $1.16 Million
Q2 2022

Aug 15, 2022

BUY
$1.19 - $1.65 $284,981 - $395,142
239,480 Added 46.92%
749,913 $1.16 Million
Q1 2022

May 16, 2022

BUY
$0.99 - $1.6 $94,730 - $153,099
95,687 Added 23.07%
510,433 $694,000
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $86,761 - $122,319
-71,116 Reduced 14.64%
414,746 $506,000
Q3 2021

Nov 10, 2021

BUY
$1.2 - $1.5 $583,034 - $728,793
485,862 New
485,862 $666,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.